AN2 Therapeutics, Inc. (ANTX) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts ANTX Hot Sheet
Join SI Premium – FREE
AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q2 EPS of ($0.81), $0.04 better than the analyst estimate of ($0.85).
For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance
- SAP stock dips after Oracle's massive AI spending plans
- Jefferies finds gaps in Australia's new climate disclosures
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
